{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00002297",
      "orgStudyIdInfo": {
        "id": "008A"
      },
      "secondaryIdInfos": [
        {
          "id": "ISO-103-USA"
        }
      ],
      "organization": {
        "fullName": "NIH AIDS Clinical Trials Information Service",
        "class": "INDUSTRY"
      },
      "briefTitle": "A Study of Isoprinosine in Patients With Lymph Node Disease",
      "officialTitle": "A Multi-Center Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Unexplained Generalized Lymphadenopathy"
    },
    "statusModule": {
      "statusVerifiedDate": "1989-06",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "studyFirstSubmitDate": "1999-11-02",
      "studyFirstSubmitQcDate": "2001-08-30",
      "studyFirstPostDateStruct": {
        "date": "2001-08-31",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2005-06-23",
      "lastUpdatePostDateStruct": {
        "date": "2005-06-24",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "leadSponsor": {
        "name": "Newport Pharmaceuticals International",
        "class": "INDUSTRY"
      }
    },
    "descriptionModule": {
      "briefSummary": "The objectives of this study are to determine the effects of isoprinosine in patients diagnosed as having unexplained generalized lymphadenopathy. Variables to be examined will include:\n\nSigns and symptoms:\n\n* Lymphadenopathy.\n* Fever.\n* Weight loss.\n* Occurrence of opportunistic infections.\n\nCell-mediated immune system parameters:\n\n* T-helper cell (OKT4) numbers and proportions.\n* T-suppressor cell (OKT8) numbers and proportions.\n* Natural killer (NK) cell activity.\n* Lymphocyte blastogenic response to phytohemagglutinin (PHA).\n* Lymphocyte blastogenic response to pokeweed mitogen (PWM).\n* Immunoglobulin (IgG, IgA, IgM, IgE, IgD) profile.\n* Circulating immune complexes. Infections characteristically associated with AIDS, such as Candida albicans, Pneumocystis carinii pneumonia, Cytomegalovirus, Herpes simplex, Cryptococcus, Histoplasma, Toxoplasma, Cryptosporidium, Mycobacterium avium- intracellulare, Legionella, and Isospora.\n\nSafety parameters:\n\n* Blood chemistry including serum uric acid (PurposeA-12).\n* Complete blood count (CBC).\n* Platelet count."
    },
    "conditionsModule": {
      "conditions": [
        "Lymphatic Disease",
        "HIV Infections"
      ],
      "keywords": [
        "Inosine Pranobex",
        "AIDS-Related Complex"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "DOUBLE"
        }
      }
    },
    "armsInterventionsModule": {
      "interventions": [
        {
          "type": "DRUG",
          "name": "Inosine pranobex"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Exclusion Criteria\n\nCo-existing Condition:\n\nPatients with a history of gout, uric acid urolithiasis, uric acid nephrolithiasis, renal dysfunction, or gastric ulceration are excluded.\n\nConcurrent Medication:\n\nExcluded:\n\n* Systemic corticosteroids.\n* Cytotoxic immunosuppressive agents.\n* Radiotherapy.\n\nCritically ill patients or those with CDC-defined AIDS are excluded.\n\nPrior Medication:\n\nExcluded within 1 month of study entry:\n\n* Immunotherapy.\n\nPatients with persistent generalized lymphadenopathy (PGL).",
      "healthyVolunteers": false,
      "sex": "MALE",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "locations": [
        {
          "facility": "Newport Pharmaceuticals International Inc",
          "city": "Laguna Hills",
          "state": "California",
          "zip": "92656",
          "country": "United States",
          "geoPoint": {
            "lat": 33.61252,
            "lon": -117.71283
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D008206",
          "term": "Lymphatic Diseases"
        },
        {
          "id": "D015658",
          "term": "HIV Infections"
        },
        {
          "id": "D000386",
          "term": "AIDS-Related Complex"
        }
      ],
      "ancestors": [
        {
          "id": "D006425",
          "term": "Hemic and Lymphatic Diseases"
        },
        {
          "id": "D000086982",
          "term": "Blood-Borne Infections"
        },
        {
          "id": "D003141",
          "term": "Communicable Diseases"
        },
        {
          "id": "D007239",
          "term": "Infections"
        },
        {
          "id": "D015229",
          "term": "Sexually Transmitted Diseases, Viral"
        },
        {
          "id": "D012749",
          "term": "Sexually Transmitted Diseases"
        },
        {
          "id": "D016180",
          "term": "Lentivirus Infections"
        },
        {
          "id": "D012192",
          "term": "Retroviridae Infections"
        },
        {
          "id": "D012327",
          "term": "RNA Virus Infections"
        },
        {
          "id": "D014777",
          "term": "Virus Diseases"
        },
        {
          "id": "D000091662",
          "term": "Genital Diseases"
        },
        {
          "id": "D000091642",
          "term": "Urogenital Diseases"
        },
        {
          "id": "D007153",
          "term": "Immunologic Deficiency Syndromes"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        },
        {
          "id": "D012897",
          "term": "Slow Virus Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D007542",
          "term": "Inosine Pranobex"
        }
      ],
      "ancestors": [
        {
          "id": "D000083",
          "term": "Acetanilides"
        },
        {
          "id": "D000813",
          "term": "Anilides"
        },
        {
          "id": "D000577",
          "term": "Amides"
        },
        {
          "id": "D009930",
          "term": "Organic Chemicals"
        },
        {
          "id": "D000814",
          "term": "Aniline Compounds"
        },
        {
          "id": "D000588",
          "term": "Amines"
        },
        {
          "id": "D007288",
          "term": "Inosine"
        },
        {
          "id": "D011684",
          "term": "Purine Nucleosides"
        },
        {
          "id": "D011687",
          "term": "Purines"
        },
        {
          "id": "D006574",
          "term": "Heterocyclic Compounds, 2-Ring"
        },
        {
          "id": "D000072471",
          "term": "Heterocyclic Compounds, Fused-Ring"
        },
        {
          "id": "D006571",
          "term": "Heterocyclic Compounds"
        },
        {
          "id": "D009705",
          "term": "Nucleosides"
        },
        {
          "id": "D009706",
          "term": "Nucleic Acids, Nucleotides, and Nucleosides"
        },
        {
          "id": "D012263",
          "term": "Ribonucleosides"
        }
      ]
    }
  },
  "hasResults": false
}